Viridian Therapeutics, Inc. (FRA:1S1)
Germany
· Delayed Price · Currency is EUR 27.45
+0.95 (3.58%)
At close: Dec 5, 2025
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of €2.63 billion as of December 5, 2025. Its market cap has increased by 73.50% in one year.
Market Cap
2.63B
Enterprise Value
2.39B
Revenue
60.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€27.45
Market Cap Chart
Since February 14, 2017, Viridian Therapeutics's market cap has increased from 162.74M to 2.63B, an increase of 1,514.19%. That is a compound annual growth rate of 37.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 179.36B |
| Allianz SE | 139.47B |
| Deutsche Telekom AG | 130.38B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.66B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |